Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Up 109.8% in December

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 8,600 shares, a growth of 109.8% from the December 15th total of 4,100 shares. Based on an average trading volume of 27,900 shares, the days-to-cover ratio is presently 0.3 days.

Bavarian Nordic A/S Stock Performance

Shares of BVNRY traded down $0.36 during trading hours on Tuesday, hitting $8.84. The company had a trading volume of 4,917 shares, compared to its average volume of 9,402. The firm has a fifty day moving average price of $9.09 and a 200-day moving average price of $10.10. The stock has a market capitalization of $2.09 billion, a price-to-earnings ratio of 12.81 and a beta of 1.65. Bavarian Nordic A/S has a 52-week low of $6.86 and a 52-week high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.